Clinical Trials Logo

Pulmonary Fibrosis clinical trials

View clinical trials related to Pulmonary Fibrosis.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT02171156 Approved for marketing - Clinical trials for Idiopathic Pulmonary Fibrosis

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)

Start date: n/a
Phase: N/A
Study type: Expanded Access

To provide early access and to evaluate the safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis (IPF).

NCT ID: NCT02141087 Approved for marketing - Clinical trials for Idiopathic Pulmonary Fibrosis

Expanded Access Program (EAP): Allow Patients in the US With Idiopathic Pulmonary Fibrosis Access to Pirfenidone

Start date: n/a
Phase: N/A
Study type: Expanded Access

This is an open label multi-center program to allow patients in the US with IPF access to treatment with pirfenidone.